A patient starts clonidine for hypertension and reports drowsiness. What should the nurse include in client education?

Introduction: Clonidine is a centrally acting alpha-2 adrenergic agonist that reduces sympathetic outflow from the central nervous system, effectively lowering blood pressure. However, its action on the brainstem often results in significant central nervous system depression, leading to sedation, drowsiness, and impaired motor coordination during initial therapy. A. Centrally acting alpha-2 agonists like clonidine frequently cause sedation and decreased mental alertness as common adverse effects. Patients must be cautioned against operating heavy machinery or driving a vehicle until the specific neurological impact of the medication has been determined and the body has potentially adjusted to the dose. B. Grapefruit juice contains compounds that inhibit the cytochrome P450 3A4 enzyme system, which can lead to increased serum levels of certain medications. It does not possess pharmacological properties that counteract sedation; in fact, increasing drug concentrations through this interaction could potentially exacerbate drowsiness and other central nervous system effects. C. Doubling the evening dose would significantly increase the total daily intake of the medication, potentially leading to profound hypotension and excessive sedation. Such a titration must only be performed by a licensed prescriber, and increasing the dose would typically worsen the drowsiness rather than alleviating the patient's concerns. D. Abrupt cessation of clonidine, especially the morning dose of a twice-daily regimen, can trigger a dangerous phenomenon known as rebound hypertension. This is characterized by a rapid and severe increase in blood pressure, tachycardia, and tremors, which can lead to hypertensive crisis and subsequent cerebrovascular or cardiac events.